Isolation of Klebsiella Oxytoca Clinical Isolate Producing AmpC β-lactamase, DHA-1
Original article PDF Wonkeun Song1, Jae-Seok Kim1, Han-Sung Kim1, Tae Jae Lee1, Min-Jeong Park1, In-Heon Park2, and Kyu Man Lee1 Department of Laboratory Medicine1and Orthopedic Surgery2, Hallym University College of Medicine, Seoul, Korea Corresponding to Wonkeun Song, E-mail: swonkeun@hallym.or.kr Ann Clin Microbiol 2004;7(2):124-129.Copyright © Korean Society of Clinical Microbiology. Abstract Background : Klebsiella oxytoca strain exhibiting an unusual inducible β-lactam resistance phenotype was isolated from a wound specimen of a patient at a university hospital in August 2002. The isolate was resistant to ampicillin, ampicillin-sulbactam, cephalothin, cefoxitin, and demonstrated reduced inhibition zone diameters for ceftazidime in combination with clavulanate versus those for ceftazidime when tested alone. Methods : Antimicrobial susceptibilities were tested using the Etest and disk diffusion method. AmpC β-lactamase production was determined by modified Hodge test. The disk antagonism method was used to detect inducibility of β-lactamase. Conjugation experiments were performed by the filter mating method using the recipient Escherichia coli J53 Azir strain. PCR and